Lansoprazole and Rybelsus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lansoprazole (lansoprazole) and Rybelsus (semaglutide). Common drug interactions include fatigue among females and dehydration among males.
The phase IV clinical study analyzes what interactions people have when they take Lansoprazole and Rybelsus. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Lansoprazole?
Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.
What is Rybelsus?
Rybelsus has active ingredients of semaglutide. eHealthMe is studying from 4,159 Rybelsus users. Check the latest studies of Rybelsus.
15 people who take Lansoprazole and Rybelsus together, and have interactions are studied.

What are the common drug interactions of Lansoprazole and Rybelsus, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Hyperhidrosis (abnormally increased sweating)
- Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Osteomyelitis (infection of bone)
- Osteonecrosis of jaw (death of bone of jaw)
- Pulmonary embolism (blockage of the main artery of the lung)
- Somnolence (a state of near-sleep, a strong desire for sleep)
male:
- Dehydration (dryness resulting from the removal of water)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Prerenal failure
- Rash erythematous (redness of the skin)
- Vomiting
- Abdominal discomfort
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Blood glucose increased
- Ketoacidosis (high concentrations of ketone bodies in blood)
- Rash pruritic (redness with itching)
What are the common drug interactions of Lansoprazole and Rybelsus, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Abdominal distension
- Glycosylated haemoglobin
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
40-49:
- Diarrhoea
- Prerenal failure
- Vomiting
- Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
- Dizziness
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Vaginal haemorrhage (vaginal bleeding)
50-59:
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Lactic acidosis (low ph in body tissues)
- Rash erythematous (redness of the skin)
- Blood glucose increased
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Ketoacidosis (high concentrations of ketone bodies in blood)
- Osteomyelitis (infection of bone)
- Osteonecrosis of jaw (death of bone of jaw)
- Pulmonary embolism (blockage of the main artery of the lung)
- Toothache (tooth pain)
60+:
- Fatigue (feeling of tiredness)
- Asthenia (weakness)
- Hyperhidrosis (abnormally increased sweating)
- Abdominal discomfort
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Dyspnoea (difficult or laboured respiration)
- Rash pruritic (redness with itching)
- Throat tightness
- Weight decreased
What are the existing conditions these people have? *
- Type 2 Diabetes: 4 people, 26.67%
- Diabetes: 3 people, 20.00%
- Ill-Defined Disorder: 2 people, 13.33%
- High Blood Cholesterol: 1 person, 6.67%
- Breast Cancer: 1 person, 6.67%
- Cerebral Haemorrhage (bleeding within the brain): 1 person, 6.67%
- Cushing's Syndrome (obesity, a rounded face, increased fat): 1 person, 6.67%
- Dyslipidaemia (abnormal amount of lipids): 1 person, 6.67%
- Ear Disorder: 1 person, 6.67%
- High Blood Pressure: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Lansoprazole and Rybelsus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lansoprazole (129,663 reports)
- Rybelsus (4,159 reports)
Browse all drug interactions of Lansoprazole and Rybelsus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lansoprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rybelsus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lansoprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rybelsus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lansoprazole and semaglutide (the active ingredients of Lansoprazole and Rybelsus, respectively), and Lansoprazole and Rybelsus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Plaquenil cause Sinus Congestion? - a second ago
- Drug interactions of Promethazine and Citalopram Hydrobromide - a second ago
- Could Lasix cause Oesophagitis Ulcerative? - 4 seconds ago
- Drug interactions of Cefotaxime Sodium and Sertraline Hydrochloride - 13 seconds ago
- Stable Angina and Sopor - 14 seconds ago
- Could Piperacillin cause Gastric Ulcer? - 17 seconds ago
- Could Nexplanon cause Drug Intolerance? - 28 seconds ago
- Refractory Anaemia With An Excess Of Blasts and Constipation - 30 seconds ago
- Hallucination, Visual and Abnormal Behavior - 36 seconds ago
- Candesartan Cilexetil vs. Lipitor, side effect and effectiveness comparison - 39 seconds ago